Metraipolis › archive › dc_65ced57bc01d

Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison — Europe PMC PMID:41301077

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41301077
DOI
10.3390/cancers17223716
License (as archived)
solo-consultazione
Archived
2026-11-08T09:40:50.368Z
SHA-256 of the archived text
cb1d731921be7bdfad5ef4d9968fd99eb172efd3541b67aa3007b780436d193e
Stable URL of this page
https://metraipolis.com/documento/dc_65ced57bc01d

How to cite

Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison — Europe PMC PMID:41301077 — Europe PMC (en), https://europepmc.org/article/MED/41301077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65ced57bc01d (Metraipolis archive dc_65ced57bc01d, sha256 cb1d731921be7bdfad5ef4d9968fd99eb172efd3541b67aa3007b780436d193e)
BibTeX
@misc{dc65ced57bc01d,
  title = {Efficacy of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric Cancer Stratified by PD-L1 Expression: A Real-World Comparison — Europe PMC PMID:41301077},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41301077},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65ced57bc01d; sha256 cb1d731921be7bdfad5ef4d9968fd99eb172efd3541b67aa3007b780436d193e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41301077. Agents can read the archived copy with the MCP tool read_document.